+Compare
XRAY
Stock ticker: NASDAQ
AS OF
Loading...
Price
Loading...
Change
Loading...
Capitalization
7.23B

XRAY DENTSPLY SIRONA Forecast, Technical & Fundamental Analysis

a global denal eqipment company

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I.Advisor
a Summary for XRAY with price predictions
08:00 PM EDT Sep 25, 2023

XRAY's Indicator enters downward trend

The Aroon Indicator for XRAY entered a downward trend on September 19, 2023. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 156 similar instances where the Aroon Indicator formed such a pattern. In of the 156 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 05, 2023. You may want to consider selling the stock, shorting the stock, or exploring put options on XRAY as a result. In of 96 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for XRAY turned negative on September 05, 2023. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 53 similar instances when the indicator turned negative. In of the 53 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where XRAY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where XRAY's RSI Oscillator exited the oversold zone, of 26 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 15 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where XRAY advanced for three days, in of 338 cases, the price rose further within the following month. The odds of a continued upward trend are .

XRAY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.952) is normal, around the industry mean (24.932). P/E Ratio (19.231) is within average values for comparable stocks, (79.196). Projected Growth (PEG Ratio) (1.868) is also within normal values, averaging (6.230). Dividend Yield (0.015) settles around the average of (0.019) among similar stocks. P/S Ratio (1.862) is also within normal values, averaging (58.009).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. XRAY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. XRAY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Abbott Laboratories (NYSE:ABT), Medtronic plc (NYSE:MDT), Intuitive Surgical (NASDAQ:ISRG), Boston Scientific Corp (NYSE:BSX), Edwards Lifesciences Corp (NYSE:EW), IQVIA Holdings (NYSE:IQV), Align Technology (NASDAQ:ALGN), Illumina (NASDAQ:ILMN), Exact Sciences Corp (NASDAQ:EXAS), Guardant Health (NASDAQ:GH).

Industry description

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

Market Cap

The average market capitalization across the Medical Specialties Industry is 6.32B. The market cap for tickers in the group ranges from 27 to 3.82T. MKYSF holds the highest valuation in this group at 3.82T. The lowest valued company is FOGCF at 27.

High and low price notable news

The average weekly price growth across all stocks in the Medical Specialties Industry was -3%. For the same Industry, the average monthly price growth was -6%, and the average quarterly price growth was -8%. FEMY experienced the highest price growth at 363%, while RHNMF experienced the biggest fall at -54%.

Volume

The average weekly volume growth across all stocks in the Medical Specialties Industry was 14%. For the same stocks of the Industry, the average monthly volume growth was 62% and the average quarterly volume growth was 174%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 72
Price Growth Rating: 66
SMR Rating: 84
Profit Risk Rating: 88
Seasonality Score: -21 (-100 ... +100)
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I. Advisor
published Earnings

XRAY is expected to report earnings to fall 5.37% to 48 cents per share on November 02

DENTSPLY SIRONA XRAY Stock Earnings Reports
Q3'23
Est.
$0.48
Q2'23
Beat
by $0.08
Q1'23
Beat
by $0.05
Q4'22
Beat
by $0.14
Q3'22
Missed
by $0.13
The last earnings report on August 02 showed earnings per share of 50 cents, beating the estimate of 43 cents. With 1.66M shares outstanding, the current market capitalization sits at 7.23B.
A.I.Advisor
published Dividends

XRAY is expected to pay dividends on October 13, 2023

DENTSPLY SIRONA XRAY Stock Dividends
A dividend of $0.14 per share will be paid with a record date of October 13, 2023, and an ex-dividend date of September 28, 2023. The last dividend of $0.14 was paid on July 14. Read more...
A.I. Advisor
published General Information

General Information

a global denal eqipment company

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
13320 Ballantyne Corporate Place
Phone
+1 844 848-0137
Employees
15000
Web
https://www.dentsplysirona.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
MAGIC.X0.4842950.015408
+3.29%
MAGIC cryptocurrency
TBJL18.63-0.03
-0.14%
Innovator 20+ Year Tsy Bd Bfr ETF July
MDLV23.22-0.24
-1.02%
Morgan Dempsey Large Cap Value ETF
SPELL.X0.000498-0.000012
-2.31%
Spell Token cryptocurrency
FTT.X1.176721-0.082497
-6.55%
FTX Token cryptocurrency

XRAY and

Correlation & Price change

A.I.dvisor indicates that over the last year, XRAY has been loosely correlated with NVST. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if XRAY jumps, then NVST could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XRAY
1D Price
Change %
XRAY100%
+1.23%
NVST - XRAY
59%
Loosely correlated
-0.04%
IDXX - XRAY
59%
Loosely correlated
-1.10%
RVTY - XRAY
58%
Loosely correlated
-1.76%
ALGN - XRAY
56%
Loosely correlated
+0.33%
IQV - XRAY
55%
Loosely correlated
-0.70%
More

Groups containing XRAY

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XRAY
1D Price
Change %
XRAY100%
+1.23%
dental
(undefined stocks)
85%
Closely correlated
-0.14%
3d printing
(undefined stocks)
66%
Closely correlated
-1.11%
medical research
(undefined stocks)
64%
Loosely correlated
+3.16%
Medical Specialties
(undefined stocks)
64%
Loosely correlated
+0.39%
Medical Specialties
(undefined stocks)
64%
Loosely correlated
+0.39%
More